Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Atherosclerosis|October 17, 2016
Effect of IL-6 receptor blockade on high-sensitivity troponin T and NT-proBNP in rheumatoid arthritisPaul Welsh, Katie Tuckwell, Iain B McInnes, et al.
Rheumatology (Oxford, England)|March 18, 2020
Regional variations in adverse event reporting rates and ACR responses in placebo/standard-of-care arms of rheumatoid arthritis trialsDaniel Keebler, Edmond Teng, Jenny Chia, et al.
Arthritis Research & Therapy|February 22, 2019
Health-related quality of life in patients with giant cell arteritis treated with tocilizumab in a phase 3 randomised controlled trialVibeke Strand, Sophie Dimonaco, Katie Tuckwell, et al.
International Journal of Rheumatology|April 17, 2015
Development and implementation of a double-blind corticosteroid-tapering regimen for a clinical trialNeil Collinson, Katie Tuckwell, Frank Habeck, et al.
Advances in Rheumatology (London, England)|December 6, 2019
Levels of CXCL13 and sICAM-1 correlate with disease activity score in patients with rheumatoid arthritis treated with tocilizumabKatie Tuckwell, Cem Gabay, Thierry Sornasse, et al.
Annals of the Rheumatic Diseases|November 29, 2015
Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritisCem Gabay, Iain B McInnes, Arthur Kavanaugh, et al.
Seminars in Arthritis and Rheumatism|July 6, 2016
Corticosteroid-related adverse events in patients with giant cell arteritis: A claims-based analysisMichael S Broder, Khaled Sarsour, Eunice Chang, et al.
Pharmaceutical Research|January 8, 2020
Population Pharmacokinetics, Efficacy Exposure-response Analysis, and Model-based Meta-analysis of Fenebrutinib in Subjects with Rheumatoid Arthritis [corrected]Phyllis Chan, Jiajie Yu, Leslie Chinn, et al.
RMD Open|September 29, 2017
Impact of tocilizumab monotherapy on patient-reported outcomes in patients with rheumatoid arthritis from two randomised controlled trialsVibeke Strand, Margaret Michalska, Christine Birchwood, et al.
Pharmaceutical Research|January 26, 2020
Correction to: Population Pharmacokinetics, Efficacy Exposure-response Analysis, and Model-based Meta-analysis of Fenebrutinib in Subjects with Rheumatoid ArthritisPhyllis Chan, Jiajie Yu, Leslie Chinn, et al.
Pageof 3